United Therapeutics Corporation (NASDAQ:UTHR) is one of the most profitable biotech stocks to invest in now.
Keep Reading →
July 28 - News
We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts.
Keep Reading →
July 25 - News
Jared Holz, Mizuho health care equity strategist, appeared on CNBC’s 'Power Lunch' on March 5 to talk about investing in biotech and the oversaturation in the sector.
Keep Reading →
July 25 - Hedge Funds, News
United Therapeutics Corporation (NASDAQ:UTHR) is one of the Best Extremely Profitable Stocks to Buy Right Now. On July 15, Analyst Joseph Thome from TD Cowen maintained a Buy...
Keep Reading →
July 25 - News
On July 23, Matt Powers, Powers Advisory Group managing partner, joined CNBC for an interview to discuss the latest market trends.
Keep Reading →
July 23 - Hedge Funds, News
The CEO of Pivotal Advisors, Tiffany McGhee, spoke on CNBC on June 27 on what investors should do in light of the current state of the market.
Keep Reading →
July 21 - Hedge Funds, News
United Therapeutics Corporation (NASDAQ:UTHR) is among the most undervalued stocks to invest in.
Keep Reading →
July 21 - News
Pharmaceutical manufacturing in the U.S. has declined sharply over recent decades, with most active ingredient production shifting overseas due to lower labor costs.
Keep Reading →
July 19 - Hedge Funds, News
United Therapeutics Corporation (NASDAQ:UTHR) is one of the high-margin pharma stocks to buy now.
Keep Reading →
July 18 - News
The pharmaceutical sector continues to stand out as a resilient and highly profitable corner of the market, even amid global economic uncertainty.
Keep Reading →
July 18 - Hedge Funds, News
Liquidia Corporation (NASDAQ:LQDA) is one of the best low priced pharma stocks to buy now.
Keep Reading →
July 15 - News
United Therapeutics Corp. (NASDAQ:UTHR) is one of the 11 best debt-free stocks to invest in right now.
Keep Reading →
July 10 - News
It is widely understood that employing debt to fund operations can act as a powerful financial tool. But debt doesn't come without its trade-offs.
Keep Reading →
July 10 - Hedge Funds, News
United Therapeutics Corporation (NASDAQ:UTHR) is one of the most undervalued US stocks according to analysts.
Keep Reading →
June 28 - News
On June 26, Noah Blackstein, Dynamic Funds senior portfolio manager, joined CNBC's 'Squawk Box' to discuss the current market and economic conditions.
Keep Reading →
June 27 - Hedge Funds, News
Even after his passing in 2024, billionaire investor and mathematician Jim Simons remains known as the "Quant King" of hedge funds due to the extraordinary success of Renaissance...
Keep Reading →
May 11 - Hedge Funds, News
United Therapeutics Corporation (NASDAQ:UTHR) Q1 2025 Earnings Call Transcript April 30, 2025United Therapeutics Corporation beats earnings expectations.
Keep Reading →
May 1 - News, Transcripts
With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.
Keep Reading →
March 30 - Hedge Funds, News
In the US, healthcare expenditures and costs have been increasing.
Keep Reading →
March 12 - Hedge Funds, News
United Therapeutics Corporation (NASDAQ:UTHR) Q4 2024 Earnings Call Transcript February 26, 2025United Therapeutics Corporation beats earnings expectations.
Keep Reading →
February 27 - News, Transcripts
The American quant hedge fund Renaissance Technologies is known for using statistical and mathematical tools to drive its investment programs.
Keep Reading →
February 22 - Hedge Funds, News
Biotechnology stocks are among the most volatile in the market due to their high risk.
Keep Reading →
February 11 - Hedge Funds, News
Investing in healthcare equities is typically seen as protective during recessionary times.
Keep Reading →
December 28 - Hedge Funds, News
Polaris Capital Management, an investment management company, released its third quarter 2024 investor letter. A copy of the same can be downloaded here.
Keep Reading →
December 23 - Hedge Fund Investor Letters, News
The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and government assistance.
Keep Reading →
December 23 - Hedge Funds, News
United Therapeutics Corporation (NASDAQ:UTHR) Q3 2024 Earnings Call Transcript October 30, 2024United Therapeutics Corporation misses on earnings expectations.
Keep Reading →
November 1 - News, Transcripts
Renaissance Technologies is an American hedge fund that specializes in systematic trading and employs statistical and mathematical tools to drive its investment programs.
Keep Reading →
October 6 - Hedge Funds, News
The current market data shows that the economy of the United States is normalizing, especially with an active Federal Reserve, global stimulus from China, and higher consumption...
Keep Reading →
September 30 - Hedge Funds, News
Recent discussions among financial strategists emphasize the current stock market dynamics, particularly regarding the upcoming US elections.
Keep Reading →
September 18 - Hedge Funds, Industries, News
United Therapeutics Corporation (NASDAQ:UTHR) Q2 2024 Earnings Call Transcript July 31, 2024United Therapeutics Corporation misses on earnings expectations.
Keep Reading →
August 1 - News, Transcripts
In this article, we will be taking a look at the 30 Most Profitable Companies with Highest Margins in the World.
Keep Reading →
May 3 - Business, Industries, Lists, News
United Therapeutics Corporation beats earnings expectations. Reported EPS is $6.17, expectations were $5.65.
Keep Reading →
May 2 - News, Transcripts
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Keep Reading →
March 17 - Lists, News
In this article, we discuss 5 most undervalued biotech stocks to buy according to hedge funds.
Keep Reading →
March 9 - News
In this article, we will be taking a look at the 5 fastest growing biotech companies in the US.
Keep Reading →
February 23 - News
United Therapeutics Corporation beats earnings expectations. Reported EPS is $4.36, expectations were $3.92.
Keep Reading →
February 22 - News, Transcripts
In this article, we discuss the 15 undervalued defensive stocks for 2024.
Keep Reading →
December 24 - Hedge Funds, News
In this article, we discuss Jim Simons and his top 10 stock picks.
Keep Reading →
December 8 - Hedge Funds, News
In this piece, we will take a look at the five biggest healthcare stocks in Jim Simons' stock portfolio.
Keep Reading →
November 13 - Hedge Funds, News
In this article, we will be taking a look at the top 20 drug companies in the US by revenue.
Keep Reading →
November 9 - Industries, Lists, News
Operator: Good morning, and welcome to the United Therapeutics Corporation Third Quarter 2023 Earnings Webcast. My name is Rocco, and I will be your conference operator today.
Keep Reading →
November 2 - News, Transcripts
In this piece, we will take a look at five cheap biotechnology stocks that smart investors are piling into.
Keep Reading →
October 20 - Hedge Funds
Operator: Good morning, and welcome to the United Therapeutics Corporation Second Quarter 2023 Earnings Webcast.
Keep Reading →
August 4 - News, Transcripts
In this piece, we will take a look at 14 best biotechnology stocks to buy according to hedge funds.
Keep Reading →
May 25 - Hedge Funds, News
In this article, we discuss billionaire Jim Simons’ top 15 stock picks in 2023.
Keep Reading →
May 19 - Hedge Funds, News
Operator: Good morning, and welcome to the United Therapeutics Corporation First Quarter 2023 Earnings Webcast.
Keep Reading →
May 4 - News, Transcripts
Operator: Good morning and welcome to the United Therapeutics Corporation Fourth Quarter and Full Year 2022 Earnings Webcast.
Keep Reading →
February 23 - News, Transcripts
One industry that has rapidly evolved with time and impacted millions, if not billions, of lives is the pharmaceutical sector.
Keep Reading →
February 23 - Lists, News
In this article, we will be taking a look at 12 cheap biotech stocks to buy.
Keep Reading →
January 25 - Hedge Funds, News
The healthcare sector in 2022 outperformed the market despite several headwinds and a negative macroeconomic backdrop.
Keep Reading →
January 21 - Hedge Funds, News